Dementia in oldest old: The challenge of multifactoriality;La demenza nel grande vecchio: La sfida della multifattorialità

Giornale di Gerontologia

Volumn 51, Issue 5, 2003, Pages 418-424

  Cucinotta, Domenico ^a   Savorani, G ^a   Reggiani, A ^a   De Notariis, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Dementia; Oldest old; Pathogenesis

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; LIPID; MEVINOLIN; PYRIDOXINE; SIMVASTATIN; TUMOR NECROSIS FACTOR;

AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; DEGENERATIVE DISEASE; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; ELDERLY CARE; ENDOTHELIUM INJURY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INCIDENCE; INTELLECTUAL IMPAIRMENT; MEDICAL RESEARCH; MEMORY DISORDER; METHODOLOGY; MICROANGIOPATHY; PATHOGENESIS; PREVALENCE; SELF CONCEPT; TREATMENT PLANNING; VASCULAR DISEASE;

EID: 1942422205     PISSN: 00170305     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Doody RS, Massman P, Dunn JK. A method for estimating progression rates in Alzheimer disease. Arch Neurol 2001;58:449-54.
2. Skoog I. A review on blood pressare and ischaemic white matter lesions. Dement Geriatric Cogn Disord 1998;9(Suppl.1):13-9.
3. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322(7300):1447-51.
4. Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, Karlsson I, et al. A population study on blood-brain barrier function in 85-years-olds: relation to Alzheimer's disease and vascular dementia. Neurology 1998;50:966-71.
5. Trabucchi M. Le demenze. Terza edizione. Utet 2003.
6. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999;53:1937-42.
7. Zubenko GS, Volicer L, Direnfeld LK, Freeman M, Langlais PJ, Nixon RA. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy. Brain Res 1985;328:215-21.
8. Selvetella G, Notte A, Maffei A, Calistri V, Scamardella V, Frati G, et al. Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients. Stroke 2003;34:1766-70.
9. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Ann Rev Med 1998;49:31-62.
10. Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R, et al. Homocysteine and cognitive function in the elderly. Neurology 2002;59:1375-80.
11. Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 2002;58:1471-5.
12. Licastro F, Pedrini S, Davis LJ, Caputo L, Tagliabue J, Savorani G, et al. 1-antichymotrypsin and oxidative stress in the peripheral blood from patients with probable Alzheimer disease: a short-term longitudinal study. Alzheimer Dis Ass Dis 2001;15:51-5.
13. Shea TB, Ekinci FJ, Ortiz D, Wilson TO, Nicolosi RJ. Efficacy of vitamin E, phosphatidyl choline and pyruvate on Abeta neurotoxicity in culture. JNHA 2003;7:252-5.
14. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Progr Neurobiol 1998;56:359-84.
15. Odetti P, Pronzato MA, Noberasco G, Cosso L, Traverso N, Cottalasso D, et al. Relationships between glycation and oxidation related fluorescences in rat collagen during aging. An in vivo and in vitro study. Lab Invest 1994; (1):61-7.
16. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci 2001;98:5856-61.
17. Tokuda T, Tamaoka A, Matsuno S, Sakurai S, Shimada H, Morita H, et al. Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins. Ann Neurol 2001;49:546-7.
18. Koudinov AR, Koudinova NV. Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J 2001;15:1858-60.
19. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, et al. Risk factors for Alzheimer's disease. a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002;156:445-53.
20. Licastro F, Parnetti L, Morini MC, Davis LJ, Cucinotta D, Gaiti A, et al. Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease. Alzheimer Dis Assoc Disord 1995;9:112-8.
21. Huberman M, Shalit F, Roth-Deri I, Gutman B, Brodie C, Kott E, et al. Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage. J Neuroimmunol 1994;52:147-52.
22. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003;60:940-6.
23. Praticò D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol 2002;59:972-6.
24. Mecocci P, Polidori MC, Cherubini A, Ingegni T, Mattioli P, Catani M, et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol 2002;59:794-8.
25. Padovani A, Borroni B, Colciaghi F, Pettenati C, Cottini E, Agosti C, et al. Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch Neurol 2002;59:71-5.
26. Goldstein LE, Muffat JA, Cherry RA, Moir RD, Ericsson MH, Huang X, et al. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. Lancet 2003;361:1258-65.
27. Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002;59:364-70.
28. Tiemeier H, Bakker SL, Hofman A, Koudstaal PJ, Breteler MM. Cerebral haemodynamics and depression in the elderly. J Neurol Neurosurg Psychiatry 2002;73:34-9.
29. Fujiwara Y, Shinkai S, Watanabe S. Characteristics of older community-welling people with mild cognitive decline. Res Pract Alzheimer Dis 2003;7:33-7.